388 related articles for article (PubMed ID: 29179732)
1. Drug repurposing for the treatment of glioblastoma multiforme.
Abbruzzese C; Matteoni S; Signore M; Cardone L; Nath K; Glickson JD; Paggi MG
J Exp Clin Cancer Res; 2017 Nov; 36(1):169. PubMed ID: 29179732
[TBL] [Abstract][Full Text] [Related]
2. Repurposing drugs for glioblastoma: From bench to bedside.
Basso J; Miranda A; Sousa J; Pais A; Vitorino C
Cancer Lett; 2018 Aug; 428():173-183. PubMed ID: 29729291
[TBL] [Abstract][Full Text] [Related]
3. Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery-A Comprehensive Review of the Literature.
Alomari S; Zhang I; Hernandez A; Kraft CY; Raj D; Kedda J; Tyler B
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944514
[TBL] [Abstract][Full Text] [Related]
4. Repurposing chlorpromazine in the treatment of glioblastoma multiforme: analysis of literature and forthcoming steps.
Abbruzzese C; Matteoni S; Persico M; Villani V; Paggi MG
J Exp Clin Cancer Res; 2020 Jan; 39(1):26. PubMed ID: 32005270
[TBL] [Abstract][Full Text] [Related]
5. Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma.
Saeed MEM; Kadioglu O; Greten HJ; Yildirim A; Mayr K; Wenz F; Giordano FA; Efferth T
Invest New Drugs; 2021 Jun; 39(3):670-685. PubMed ID: 33313992
[TBL] [Abstract][Full Text] [Related]
6. Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma.
Rundle-Thiele D; Head R; Cosgrove L; Martin JH
Br J Clin Pharmacol; 2016 Feb; 81(2):199-209. PubMed ID: 26374633
[TBL] [Abstract][Full Text] [Related]
7. Glioblastoma as a Novel Drug Repositioning Target: Updated State.
Hosseinalizadeh H; Ebrahimi A; Tavakoli A; Monavari SH
Anticancer Agents Med Chem; 2023; 23(11):1253-1264. PubMed ID: 36733195
[TBL] [Abstract][Full Text] [Related]
8. Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma.
Persico M; Abbruzzese C; Matteoni S; Matarrese P; Campana AM; Villani V; Pace A; Paggi MG
Cells; 2022 Jan; 11(2):. PubMed ID: 35053377
[TBL] [Abstract][Full Text] [Related]
9. From GWAS to drug screening: repurposing antipsychotics for glioblastoma.
Lin WZ; Liu YC; Lee MC; Tang CT; Wu GJ; Chang YT; Chu CM; Shiau CY
J Transl Med; 2022 Feb; 20(1):70. PubMed ID: 35120529
[TBL] [Abstract][Full Text] [Related]
10. Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets.
Mao H; Lebrun DG; Yang J; Zhu VF; Li M
Cancer Invest; 2012 Jan; 30(1):48-56. PubMed ID: 22236189
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced modifications and modulations of microRNAs and long non-coding RNAs for future therapy against Glioblastoma Multiforme.
Janaki Ramaiah M; Divyapriya K; Kartik Kumar S; Rajesh YBRD
Gene; 2020 Jan; 723():144126. PubMed ID: 31589963
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathways and potential therapeutic targets in glioblastoma multiforme.
Wardak Z; Choe KS
Expert Rev Anticancer Ther; 2013 Nov; 13(11):1307-18. PubMed ID: 24168050
[TBL] [Abstract][Full Text] [Related]
13. [The sodium pump could constitute a new target to combat glioblastomas].
Lefranc F; Mijatovic T; Kiss R
Bull Cancer; 2008 Mar; 95(3):271-81. PubMed ID: 18390407
[TBL] [Abstract][Full Text] [Related]
14. SnapShot: glioblastoma multiforme.
Kotliarova S; Fine HA
Cancer Cell; 2012 May; 21(5):710-710.e1. PubMed ID: 22624719
[No Abstract] [Full Text] [Related]
15. Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date.
Bastien JI; McNeill KA; Fine HA
Cancer; 2015 Feb; 121(4):502-16. PubMed ID: 25250735
[TBL] [Abstract][Full Text] [Related]
16. Molecular targeted therapy of glioblastoma.
Le Rhun E; Preusser M; Roth P; Reardon DA; van den Bent M; Wen P; Reifenberger G; Weller M
Cancer Treat Rev; 2019 Nov; 80():101896. PubMed ID: 31541850
[TBL] [Abstract][Full Text] [Related]
17. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
[TBL] [Abstract][Full Text] [Related]
18. Targeting metabolic remodeling in glioblastoma multiforme.
Wolf A; Agnihotri S; Guha A
Oncotarget; 2010 Nov; 1(7):552-62. PubMed ID: 21317451
[TBL] [Abstract][Full Text] [Related]
19. Activation of KATP channels increases anticancer drug delivery to brain tumors and survival.
Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats T
Eur J Pharmacol; 2009 Jan; 602(2-3):188-93. PubMed ID: 19027730
[TBL] [Abstract][Full Text] [Related]
20. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.
Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM
Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
